Tag Archives: ANXA2

Glioblastoma: Remission Rather Than Progression

For the first time American neurosurgeons have employed genetically modified T cells in the treatment of a solid tumour. One patient with recurrent and multifocal glioblastoma ended up being in remission for about seven months. more...

Click here and become a medical blogger!
Copyright © 2018 DocCheck Medical Services GmbH
Language:
Follow DocCheck: